A fatal case of hidradenitis suppurativa associated with sepsis and squamous cell carcinoma

International Journal of Dermatology

Volumn 55, Issue 1, 2016, Pages e52-e53

  Verdelli, Alice ^a   Antiga, Emiliano ^a   Bonciani, Diletta ^a   Bonciolini, Veronica ^a   Volpi, Walter ^a   Caproni, Marzia ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; COLISTIN; CORTICOSTEROID; INFLIXIMAB; ISOTRETINOIN; RIFAMPICIN;

ABSCESS; ACINETOBACTER BAUMANNII; AGED; CASE REPORT; DEATH; DETERIORATION; DISEASE ASSOCIATION; DISEASE COURSE; DRUG WITHDRAWAL; FATALITY; HUMAN; IMPOTENCE; LETTER; MALE; OFF LABEL DRUG USE; PAIN; PHYSICAL EXAMINATION; RECURRENT DISEASE; SEPSIS; SKIN FISTULA; SKIN NODULE; SQUAMOUS CELL CARCINOMA; SUPPURATIVE HIDRADENITIS; WALKING DIFFICULTY; BUTTOCK; CARCINOMA, SQUAMOUS CELL; COMPLICATION; HIDRADENITIS SUPPURATIVA; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SKIN NEOPLASMS;

AGED; BUTTOCKS; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; FATAL OUTCOME; HIDRADENITIS SUPPURATIVA; HUMANS; MALE; RISK ASSESSMENT; SEPSIS; SEVERITY OF ILLNESS INDEX; SKIN NEOPLASMS;

EID: 84953839427     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/ijd.13006     Document Type: Letter

References (10)

1. Bahillo Monné C, Honorato Guerra S, SchoendorffOrtega C, et al. Management of hidradenitis suppurativa with biological therapy: report of four cases and review of the literature. Dermatology 2014; 229: 279-287.
2. Vogelaar FJ, Willems JM. Squamous cell carcinoma as a rare complication of hidradenitis suppurativa. Ned Tijdschr Geneeskd 2010; 154: A1137.
3. Fimmel S, Zouboulis CC. Comorbidities of hidradenitis suppurativa (acne inversa). Dermatoendocrinol 2010; 2: 9-16.
4. Asgeirsson T, Nunoo R, Luchtefeld MA. Hidradenitis suppurativa and pruritus ani. Clin Colon Rectal Surg. 2011; 24: 71-80.
5. Maclean GM, Coleman DJ. Three fatal cases of squamous cell carcinoma arising in chronic perineal hidradenitis suppurativa. Ann R Coll Surg Engl 2007; 89: 709-712.
6. Herschel S, Laske J, Stein A. Squamous cell carcinoma arising in hidradenitis suppurativa. J Dtsch Dermatol Ges 2014; 12: 417-419.
7. Scheinfeld N. A case of a patient with stage III familial hidradenitis suppurativa treated with 3 courses of infliximab and died of metastatic squamous cell carcinoma. Dermatol Online J 2012; 17: 20.
8. Lesage C, Adnot-Desanlis L, Perceau G, et al. Efficacy and tolerance of prolonged infliximab treatment of moderate-to-severe forms of hidradenitis suppurativa. Eur J Dermatol 2012; 22: 640-644.
9. Brunasso AM, Massone C. Treatment of hidradenitis suppurativa with tumor necrosis factor-α inhibitors: an update on infliximab. Acta Derm Venereol 2011; 91: 70-71.
10. Kelly G, Sweeney CM, Tobin AM, et al. Hidradenitis suppurativa: the role of immune dysregulation. Int J Dermatol 2014; 53: 1186-1196.